Glenmark Pharmaceuticals Limited
GLENMARK.NS
1441
INR+23.60
(+1.67%)Day's range
1407.1
1449.7
52 wk Range
985.2
1830.95
GLENMARK.NS Ratios
| Period Ending | — |
|---|---|
| Dividend Yield (TTM) | 0.002 |
| Dividend Yield Percentage (TTM) | 0.173 |
| Price-to-Earnings Ratio (TTM) | -231.269 |
| Price/Earnings-to-Growth Ratio (TTM) | -2.894 |
| Payout Ratio (TTM) | 0 |
| Current Ratio (TTM) | 1.461 |
| Quick Ratio (TTM) | 1.001 |
| Cash Ratio (TTM) | 0.294 |
| Days of Sales Outstanding (TTM) | 80.337 |
| Days of Inventory Outstanding (TTM) | 186.66 |
| Operating Cycle (TTM) | 266.997 |
| Days of Payables Outstanding (TTM) | 155.267 |
| Cash Conversion Cycle (TTM) | 111.73 |
| Gross Profit Margin (TTM) | 0.573 |
| Operating Profit Margin (TTM) | 0.137 |
| Pre-tax Profit Margin (TTM) | 0.148 |
| Net Profit Margin (TTM) | -0.014 |
| Effective Tax Rate (TTM) | 1.102 |
| Return on Assets (TTM) | -0.012 |
| Return on Equity (TTM) | -0.021 |
| Return on Capital Employed (TTM) | 0.197 |
| Net Income per Earnings Before Tax (TTM) | -0.091 |
| Earnings Before Tax per EBIT (TTM) | 1.078 |
| EBIT per Revenue (TTM) | 0.137 |
| Debt Ratio (TTM) | 0.117 |
| Debt-to-Equity Ratio (TTM) | 0.211 |
| Long-Term Debt to Capitalization (TTM) | 0 |
| Total Debt to Capitalization (TTM) | 0.174 |
| Interest Coverage Ratio (TTM) | 6.17 |
| Cash Flow to Debt Ratio (TTM) | 0.165 |
| Equity Multiplier (TTM) | 1.804 |
| Receivables Turnover Ratio (TTM) | 4.543 |
| Payables Turnover Ratio (TTM) | 2.351 |
| Inventory Turnover Ratio (TTM) | 1.955 |
| Fixed Asset Turnover Ratio (TTM) | 3.664 |
| Asset Turnover Ratio (TTM) | 0.854 |
| Operating Cash Flow per Share (TTM) | 10.423 |
| Free Cash Flow per Share (TTM) | 10.423 |
| Cash per Share (TTM) | 72.312 |
| Operating Cash Flow to Sales Ratio (TTM) | 0.023 |
| Free Cash Flow to Operating Cash Flow Ratio (TTM) | 1 |
| Cash Flow Coverage Ratio (TTM) | 0.165 |
| Short-Term Coverage Ratio (TTM) | 0.188 |
| Capital Expenditure Coverage Ratio (TTM) | 0 |
| Dividend Paid & CapEx Coverage Ratio (TTM) | 0 |
| Price-to-Book Value Ratio (TTM) | 4.815 |
| Price-to-Book Ratio (TTM) | 4.815 |
| Price-to-Sales Ratio (TTM) | 3.126 |
| Price-to-Earnings Ratio (TTM) | -231.269 |
| Price-to-Free Cash Flow Ratio (TTM) | 138.246 |
| Price-to-Operating Cash Flow Ratio (TTM) | 138.25 |
| Price-to-Cash Flow Ratio (TTM) | 138.25 |
| Price/Earnings-to-Growth Ratio (TTM) | -2.894 |
| Price-to-Sales Ratio (TTM) | 3.126 |
| Enterprise Value Multiple (TTM) | 14.919 |
| Price-to-Fair Value Ratio (TTM) | 4.815 |
| Dividend per Share (TTM) | 2.5 |